Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99996424 | 9999642 | 4 | F | 20160714 | 20140228 | 20160720 | EXP | PHEH2013US002433 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160720 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99996424 | 9999642 | 1 | PS | SANDIMMUNE NEORAL | CYCLOSPORINE | 1 | Oral | 5 DF DAILY (3 CAPSULE, (75 MG) IN MORNING AND 2 CAPSULE (50 MG) IN EVENING) | U | F0038, F0040 | 50715 | 5 | DF | CAPSULE | |||||
| 99996424 | 9999642 | 2 | SS | SANDIMMUNE NEORAL | CYCLOSPORINE | 1 | U | 50715 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 99996424 | 9999642 | 1 | Complications of transplanted kidney |
| 99996424 | 9999642 | 2 | Renal transplant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 99996424 | 9999642 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 99996424 | 9999642 | Dementia | |
| 99996424 | 9999642 | Intraocular melanoma | |
| 99996424 | 9999642 | Neoplasm malignant | |
| 99996424 | 9999642 | Neoplasm skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |